Cargando…

Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF‐κB signalling pathway

Synovial macrophage polarization and inflammation are essential for osteoarthritis (OA) development, yet the molecular mechanisms and regulation responsible for the pathogenesis are still poorly understood. Here, we report that pseudolaric acid B (PAB) attenuated articular cartilage degeneration and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jiansen, Guan, Hong, Wu, Dan, Hu, Zhiqiang, Zhang, Hongbo, Jiang, Huaji, Yu, Jingyao, Zeng, Ke, Li, Hongyu, Zhang, Haiyan, Pan, Chenglong, Cai, Daozhang, Yu, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278075/
https://www.ncbi.nlm.nih.gov/pubmed/34117708
http://dx.doi.org/10.1111/jcmm.16670
_version_ 1783722191249997824
author Lu, Jiansen
Guan, Hong
Wu, Dan
Hu, Zhiqiang
Zhang, Hongbo
Jiang, Huaji
Yu, Jingyao
Zeng, Ke
Li, Hongyu
Zhang, Haiyan
Pan, Chenglong
Cai, Daozhang
Yu, Xiao
author_facet Lu, Jiansen
Guan, Hong
Wu, Dan
Hu, Zhiqiang
Zhang, Hongbo
Jiang, Huaji
Yu, Jingyao
Zeng, Ke
Li, Hongyu
Zhang, Haiyan
Pan, Chenglong
Cai, Daozhang
Yu, Xiao
author_sort Lu, Jiansen
collection PubMed
description Synovial macrophage polarization and inflammation are essential for osteoarthritis (OA) development, yet the molecular mechanisms and regulation responsible for the pathogenesis are still poorly understood. Here, we report that pseudolaric acid B (PAB) attenuated articular cartilage degeneration and synovitis during OA. PAB, a diterpene acid, specifically inhibited NF‐κB signalling and reduced the production of pro‐inflammatory cytokines, which further decreased M1 polarization and vessel formation. We further provide in vivo and in vitro evidences that PAB suppressed NF‐κB signalling by stabilizing PPARγ. Using PPARγ antagonist could abolish anti‐inflammatory effect of PAB and rescue the activation of NF‐κB signalling during OA. Our findings identify a previously unrecognized role of PAB in the regulation of OA and provide mechanisms by which PAB regulates NF‐κB signalling through PPARγ, which further suggest targeting synovial inflammation or inhibiting vessel formation at early stage could be an effective preventive strategy for OA.
format Online
Article
Text
id pubmed-8278075
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82780752021-07-15 Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF‐κB signalling pathway Lu, Jiansen Guan, Hong Wu, Dan Hu, Zhiqiang Zhang, Hongbo Jiang, Huaji Yu, Jingyao Zeng, Ke Li, Hongyu Zhang, Haiyan Pan, Chenglong Cai, Daozhang Yu, Xiao J Cell Mol Med Original Articles Synovial macrophage polarization and inflammation are essential for osteoarthritis (OA) development, yet the molecular mechanisms and regulation responsible for the pathogenesis are still poorly understood. Here, we report that pseudolaric acid B (PAB) attenuated articular cartilage degeneration and synovitis during OA. PAB, a diterpene acid, specifically inhibited NF‐κB signalling and reduced the production of pro‐inflammatory cytokines, which further decreased M1 polarization and vessel formation. We further provide in vivo and in vitro evidences that PAB suppressed NF‐κB signalling by stabilizing PPARγ. Using PPARγ antagonist could abolish anti‐inflammatory effect of PAB and rescue the activation of NF‐κB signalling during OA. Our findings identify a previously unrecognized role of PAB in the regulation of OA and provide mechanisms by which PAB regulates NF‐κB signalling through PPARγ, which further suggest targeting synovial inflammation or inhibiting vessel formation at early stage could be an effective preventive strategy for OA. John Wiley and Sons Inc. 2021-06-11 2021-07 /pmc/articles/PMC8278075/ /pubmed/34117708 http://dx.doi.org/10.1111/jcmm.16670 Text en © 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Lu, Jiansen
Guan, Hong
Wu, Dan
Hu, Zhiqiang
Zhang, Hongbo
Jiang, Huaji
Yu, Jingyao
Zeng, Ke
Li, Hongyu
Zhang, Haiyan
Pan, Chenglong
Cai, Daozhang
Yu, Xiao
Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF‐κB signalling pathway
title Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF‐κB signalling pathway
title_full Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF‐κB signalling pathway
title_fullStr Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF‐κB signalling pathway
title_full_unstemmed Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF‐κB signalling pathway
title_short Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF‐κB signalling pathway
title_sort pseudolaric acid b ameliorates synovial inflammation and vessel formation by stabilizing pparγ to inhibit nf‐κb signalling pathway
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278075/
https://www.ncbi.nlm.nih.gov/pubmed/34117708
http://dx.doi.org/10.1111/jcmm.16670
work_keys_str_mv AT lujiansen pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway
AT guanhong pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway
AT wudan pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway
AT huzhiqiang pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway
AT zhanghongbo pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway
AT jianghuaji pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway
AT yujingyao pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway
AT zengke pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway
AT lihongyu pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway
AT zhanghaiyan pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway
AT panchenglong pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway
AT caidaozhang pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway
AT yuxiao pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway